Dr. Andreas Uttenweiler MBA

Member of the Leadership Team, Market Access & Public Affairs

Member of the Country Leadership Team Motivating, Inspiring and Developing Team of 8 employees (Market Access, In-Field Access, Patient Advocacy, External Communications) Member of Interpharma Health Care Systems Working Group Board Member of Rare Disease Action Forum

*Achieved national listing/reimbursement for 5 drugs since 2017 *Negotiated of contracts/agreements with key stakeholders (Federal Office of Public Health, key accounts, hospitals, payers) *Participated in pharma association working groups, initiated task force *Moderated & participated as panel speaker with key exponents and policy makers *Several awards for Shire-Baxalta integration, people, innovation, growth, engage with world, improving lives, creativity, team, excellent launches

*Market access: pricing & reimbursement (BAG/SL, SwissDRG, Art. 71, health insurers etc.), market access working group member at VIPS pharma association *Patient advocacy *Project Lead Economic Footprint PanAlpine *Compliance board member *Applause Award for Launch Readiness Review 2016

*Farydak MM & Glivec GIST *prepare market & company for new product launch *establish relationship with key customers *transpose innovative ideas in communication & education *develop/drive/execute robust forecasting & brand/tactical plans with clear deliverables, timelines, investments & responsibilities *represent country in European brand teams *continuous education

*New Products, digital strategy, Glivec GIST & Loss of Exclusivity *project management: introduce LaunchPad & LINX CRM *project management: Customer Focusing Model of the Future (CFM) *lead digital strategy/eMarketing *LCM: drive Loss of Exclusivity strategy *prepare market for new products/indications *represent country in European brand teams *continuous education *Novartis Pharma Switzerland Gold Award (category: team work) 2013

Product Manager Afinitor RCC & Glivec GIST *demonstrate high growth and defend market share *drive key brand initiatives to support brand value proposition and customer value added *grow relationship with key customers *transpose innovative ideas in advertising, mailings, communication & education *develop/drive/execute robust brand/tactical plans with clear deliverables, timelines, investments & responsibilities *manage A&P spend & meet A&P targets in line with phasing & budget *align plans/tactic

portfolio: oncology & respiratory products; lead eCTD implementation *Pre-approval: project coordination, DRA representative in international/cross-functional project teams (HQ/in-house), planning/coordination/realization of national regulatory strategy/submissions *Post-approval: up-to-date regulatory expertise/maintenance/compliance/archiving incl. product information/ publishing/CMC/database/document management *buiding up/maintenance of good contacts with external (regulatory authority) and intern

*speaker at international conference "comparability for biologics" 2007 in Berlin *publications in internal/external journals *elaboration of electronic archiving concept *CMC technical writing & review *editor/publisher of monthly "regulatory intelligence newsletter" *scientific support of global tech services

Boehringer Ingelheim Fonds (D)

Max-Planck Insitute Tuebingen (D), Cambridge University (UK), Boehringer Ingelheim Fonds (D)